Three basic characteristics of the tuberculin reaction to be observed in the prophylactic treatment of positive reactors.
D000917:Antibody Formation; D000995:Antitubercular Agents / Q000627:therapeutic use*; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D012867:Skin / Q000276:immunology; D014374:Tuberculin Test; D014376:Tuberculosis / Q000276:immunology / Q000517:prevention & control*
D000995:Antitubercular Agents; D007538:Isoniazid